Comparison of controlled-release nifedipine + standard-dose candesartan versus up-titrated candesartan in patients with hypertension.

Trial Profile

Comparison of controlled-release nifedipine + standard-dose candesartan versus up-titrated candesartan in patients with hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Sep 2016

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Nifedipine (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms NICE-Combi
  • Most Recent Events

    • 29 Sep 2016 Results of subanalysis (the relationship between the change of urinary albumin excretion and the changes of serum uric acid) presented at the 26th Scientific Meeting of the International Society of Hypertension
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top